Consistent with results from the KEYNOTE studies [5, 57], treatment with standard-of-care chemotherapy alone was not as effective in controlling tumor growth compared to combinatorial treatment with a PD-1 inhibitor. This evidence concerns the gene PDCD1 and neoplasm.